Infectious diseases: COVID-19

Open Access
End of the pandemic is in sight, says WHO. What does that mean for Canada?
Diana Duong

CMAJ October 03, 2022 194 (38) E1329-E1330; DOI: https://doi.org/10.1503/cmaj.1096019
Open Access
Health Services: A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens
Isha Berry, Kevin A. Brown, Sarah A. Buchan, Karin Hohenadel, Jeffrey C. Kwong, Samir Patel, Laura C. Rosella, Sharmistha Mishra and Beate Sander

CMAJ September 19, 2022 194 (36) E1250-E1254; DOI: https://doi.org/10.1503/cmaj.220577
Open Access
Five things to know about …: NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
Sabina Vohra-Miller and Ilan S. Schwartz

CMAJ September 12, 2022 194 (35) E1214; DOI: https://doi.org/10.1503/cmaj.220688
Open Access
Emerging clues to unexplained pediatric hepatitis
Diana Duong and Lauren Vogel

CMAJ September 06, 2022 194 (34) E1177-E1178; DOI: https://doi.org/10.1503/cmaj.1096015
Open Access
Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study
Victoria G. Hall, Javier T. Solera, Ghadeer Al-Alahmadi, Tina Marinelli, Heloise Cardinal, Charles Poirier, Geneviève Huard, G.V. Ramesh Prasad, Sacha A. De Serres, Debra Isaac, Rahul Mainra, Caroline Lamarche, Ruth Sapir-Pichhadze, Susan Gilmour, Atul Humar and Deepali Kumar

CMAJ August 29, 2022 194 (33) E1155-E1163; DOI: https://doi.org/10.1503/cmaj.220620
Open Access
Cases: Functional neurologic disorder associated with SARS-CoV-2 vaccination
Annie Zhu and Matthew J. Burke

CMAJ August 15, 2022 194 (31) E1086-E1088; DOI: https://doi.org/10.1503/cmaj.220039
Open Access
Five things to know about …: Severe acute hepatitis of unknown cause in children
Michelle Science, Aaron Campigotto and Vicky L. Ng

CMAJ August 15, 2022 194 (31) E1089; DOI: https://doi.org/10.1503/cmaj.220956
Open Access
Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario
Janet Smylie, Stephanie McConkey, Beth Rachlis, Lisa Avery, Graham Mecredy, Raman Brar, Cheryllee Bourgeois, Brian Dokis, Stephanie Vandevenne and Michael A. Rotondi

CMAJ August 02, 2022 194 (29) E1018-E1026; DOI: https://doi.org/10.1503/cmaj.212147
Open Access
Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
Tyler Pitre, Rebecca Van Alstine, Genevieve Chick, Gareth Leung, David Mikhail, Ellen Cusano, Faran Khalid and Dena Zeraatkar

CMAJ July 25, 2022 194 (28) E969-E980; DOI: https://doi.org/10.1503/cmaj.220471
Open Access
Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances
Corinne M. Hohl and Andrew D. McRae

CMAJ July 25, 2022 194 (28) E996-E997; DOI: https://doi.org/10.1503/cmaj.221012

Main menu

User menu

Search

Infectious diseases: COVID-19

Pages

Content

Information for

About